Lynn Welsh & Amanda Lipski, The Olson Research Group, Inc.
as published in the November 2015 issue of Quirk’s magazine

With the US healthcare system on pace to spend more than $150B treating cancer by the year 2020, payers are implementing novel methods in an attempt to curtail costs, including incentivizing physicians to adhere to suggested treatment regimens. This practice has the potential to not only reduce costs, but also to suggest that payers, and not physicians, are directing care.

How do physicians feel about this approach? Olson Research’s deep oncology access enabled us to fully explore this provocative subject. As featured in the most recent edition of Quirk’s Marketing Research Review, our white paper reveals oncologists have very strong feelings on this topic.

Download Article (PDF)